Reviewing the Latest Advancements in Plasma-Based Tau Biomarkers for Alzheimer’s Disease: High-sensitivity Assays for Tau Modifications
Time: 10:00 am
day: Pre-Conference Day
Details:
- Overcoming the low levels of modified tau in blood via enrichment and high-sensitivity assays to enable less invasive monitoring
- Highlighting the promise of plasma-based p-tau assays to detect Alzheimer’s even earlier and in broader populations
- Emerging evidence of tau fragments as unique pathological biomarkers
